‘Fycompa’ turned in the registration of the health insurance benefit, giving an advance notice as a new mechanism of epilepsy treatment

Published: 2015-07-31 13:38:56

Updated: 2015-07-31 13:38:56

A prescription option for a new mechanism of epilepsy treatment is going to be added.

According to the industry concerned on the 30^th, Eisai has turned in a registration application of the health insurance benefit for the domestically approved epilepsy treating new drug, ‘Fycompa(perampanel).’

Fycompa has acquired indication on the adjuvant therapy to treat partial seizure with or without the...

Fees

- Email service daily and homepage access.

$300 per month.
5 Email holders per each company.
Anual contract base.